UPDF AI

Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes

Y. Shi,C. Pan,J. Hill,Y. Gao

2005 · DOI: 10.1111/j.1464-5491.2005.01723.x
Diabetic Medicine · 41 citaten

TLDR

The efficacy of 24 weeks’ treatment with orlistat, combined with a mildly reduced‐calorie diet, on weight loss and glycaemic control in overweight and obese patients with newly diagnosed and previously untreated Type 2 diabetes is evaluated.